Search by Drug Name or NDC
NDC 54859-0120-04 Dermagesic .4; 1; .4 mg/100mL; mg/100mL; mg/100mL Details
Dermagesic .4; 1; .4 mg/100mL; mg/100mL; mg/100mL
Dermagesic is a TOPICAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Llorens Pharmaceuticals International Division. The primary component is FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE.
Product Information
NDC | 54859-0120 |
---|---|
Product ID | 54859-120_bdc7538b-60af-4dce-b072-ad2a91cb7716 |
Associated GPIs | 90859903970920 |
GCN Sequence Number | 076346 |
GCN Sequence Number Description | pramoxine/zinc oxide/calamine LOTION 1-0.4-0.4% TOPICAL |
HIC3 | L3P |
HIC3 Description | ANTIPRURITICS,TOPICAL |
GCN | 41815 |
HICL Sequence Number | 043598 |
HICL Sequence Number Description | PRAMOXINE HCL/ZINC OXIDE/CALAMINE |
Brand/Generic | Brand |
Proprietary Name | Dermagesic |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Pramoxine HCl, Zinc Oxide, Calamine |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | TOPICAL |
Active Ingredient Strength | .4; 1; .4 |
Active Ingredient Units | mg/100mL; mg/100mL; mg/100mL |
Substance Name | FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE |
Labeler Name | Llorens Pharmaceuticals International Division |
Pharmaceutical Class | Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part347 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 54859-0120-04 (54859012004)
NDC Package Code | 54859-120-04 |
---|---|
Billing NDC | 54859012004 |
Package | 118 mL in 1 BOTTLE (54859-120-04) |
Marketing Start Date | 2014-01-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 8b3f8894-1ed7-4888-a42c-8510d6161edd Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Do not use
- on large areas of the body
- with any other product containing diphenhydramine, even one taken by mouth
Ask a doctor before use
- on chicken pox
- on measles
Stop use and ask a doctor if condition worsens or does not improve within 7 days
- symptoms persist for more than 7 days or clear up and occur again within a few days
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
DERMAGESIC
pramoxine hcl, zinc oxide, calamine liquid |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Labeler - Llorens Pharmaceuticals International Division (037342305) |
Revised: 12/2020
Document Id: bdc7538b-60af-4dce-b072-ad2a91cb7716
Set id: 8b3f8894-1ed7-4888-a42c-8510d6161edd
Version: 2
Effective Time: 20201223